首页> 外文OA文献 >Structural basis for complement factor I control and its disease-associated sequence polymorphisms
【2h】

Structural basis for complement factor I control and its disease-associated sequence polymorphisms

机译:补体因子I控制的结构基础及其与疾病相关的序列多态性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The complement system is a key component of innate and adaptive immune responses. Complement regulation is critical for prevention and control of disease. We have determined the crystal structure of the complement regulatory enzyme human factor I (fI). FI is in a proteolytically inactive form, demonstrating that it circulates in a zymogen-like state despite being fully processed to the mature sequence. Mapping of functional data from mutants of fI onto the structure suggests that this inactive form is maintained by the noncatalytic heavy-chain allosterically modulating activity of the light chain. Once the ternary complex of fI, a cofactor and a substrate is formed, the allosteric inhibition is released, and fI is oriented for cleavage. In addition to explaining how circulating fI is limited to cleaving only C3b/C4b, our model explains the molecular basis of disease-associated polymorphisms in fI and its cofactors.
机译:补体系统是先天性和适应性免疫反应的关键组成部分。补体调节对于预防和控制疾病至关重要。我们已经确定了补体调节酶人因子I(fI)的晶体结构。 FI以蛋白水解无活性形式存在,表明尽管它已完全加工成成熟序列,但仍以酶原样状态循环。来自fI突变体的功能数据到结构的映射表​​明,这种非活性形式通过轻链的非催化重链变构调节活性得以维持。一旦形成了fI,辅因子和底物的三元复合物,就释放了变构抑制作用,并且将fI定向为可裂解的。除了解释循环fI如何仅限于仅裂解C3b / C4b之外,我们的模型还解释了fI及其辅助因子中与疾病相关的多态性的分子基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号